StockData

RxSight, Inc. (RXST) stock

RXSTNasdaqOphthalmic GoodsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3076% below fair value
$4.83−0.47 (-8.87%)

Close on Nov 17, 2026Market cap $200.90MP/E –Yield –

RxSight price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

RxSight's price to book ratio was 0.8× on Nov 11, 2026, against 1.7× a year earlier. Over the last 5 years it ranged from 0.7× to 13.6×, with a median of 3.3×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.8×−0.7
2025Dec 31, 20251.6×−3.4
2024Dec 31, 20245.0×−4.0
2023Dec 29, 20239.0×+5.3
2022Dec 30, 20223.7×+1.6
2021Dec 31, 20212.0×–

More RxSight figures

See a number that looks wrong?